{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:14:04Z","timestamp":1780103644236,"version":"3.54.0"},"reference-count":58,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Uterine leiomyomas (fibroids) are the most prevalent medical problem of the female reproductive tract, but there are few non-surgical treatment options. Although many advances in the understanding of the molecular components of these tumors have occurred over the past five years, an effective pharmaceutical approach remains elusive. Further, there is currently no clinical method to distinguish a benign uterine leiomyoma from a malignant leiomyosarcoma prior to treatment, a pressing need given concerns about the use of the power morcellator for minimally invasive surgery. This paper reviews current studies regarding the molecular biology of uterine fibroids, discusses non-surgical approaches and suggests new cutting-edge therapeutic and diagnostic approaches.<\/ns4:p>","DOI":"10.12688\/f1000research.6189.1","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T12:05:27Z","timestamp":1436184327000},"page":"183","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management"],"prefix":"10.12688","volume":"4","author":[{"given":"Darlene K.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Holthouser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis C.","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"100-7","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.","volume":"188","author":"D Baird","year":"2003","journal-title":"Am J Obstet Gynecol."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"211.e1-9","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States.","volume":"206","author":"E Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"ref-3","first-page":"225-36","article-title":"The impact of uterine leiomyomas on reproductive outcomes.","volume":"62","author":"H Cook","year":"2010","journal-title":"Minerva Ginecol."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"19887-92","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women.","volume":"105","author":"S Peddada","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"415-20","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.","volume":"195","author":"P Leppert","year":"2006","journal-title":"Am J Obstet Gynecol."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"204-17","DOI":"10.1002\/gcc.20035","article-title":"Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids.","volume":"40","author":"W Catherino","year":"2004","journal-title":"Genes Chromosomes Cancer."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"361-8","DOI":"10.1042\/BJ20111996","article-title":"Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition.","volume":"443","author":"D Carrino","year":"2012","journal-title":"Biochem J."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"1182-7","DOI":"10.1016\/j.fertnstert.2004.04.030","article-title":"Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium.","volume":"82","author":"P Leppert","year":"2004","journal-title":"Fertil Steril."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"179-94","DOI":"10.1007\/s12079-014-0234-x","article-title":"Matrix production and remodeling as therapeutic targets for uterine leiomyoma.","volume":"8","author":"C Fujisawa","year":"2014","journal-title":"J Cell Commun Signal."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1095\/biolreprod.114.121368","article-title":"Dynamic reciprocity between cells and their microenvironment in reproduction.","volume":"92","author":"J Thorne","year":"2015","journal-title":"Biol Reprod."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"783289","DOI":"10.1155\/2014\/783289","article-title":"The extracellular matrix contributes to mechanotransduction in uterine fibroids.","volume":"2014","author":"P Leppert","year":"2014","journal-title":"Obstet Gynecol Int."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"1093-107","DOI":"10.1177\/1933719114542023","article-title":"Mechanical signaling in reproductive tissues: mechanisms and importance.","volume":"21","author":"S Jorge","year":"2014","journal-title":"Reprod Sci."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"178-93","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma.","volume":"100","author":"M Islam","year":"2013","journal-title":"Fertil Steril."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1095\/biolreprod.114.123794","article-title":"Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma.","volume":"91","author":"M Ono","year":"2014","journal-title":"Biol Reprod."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1-12","DOI":"10.1093\/humupd\/dmu048","article-title":"Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.","volume":"21","author":"M Moravek","year":"2015","journal-title":"Hum Reprod Update."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"43-53","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing.","volume":"369","author":"M Mehine","year":"2013","journal-title":"N Engl J Med."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"568-72","DOI":"10.1097\/PGP.0000000000000096","article-title":"Uterine fibroids: do we deal with more than one disease?","volume":"33","author":"D Markowski","year":"2014","journal-title":"Int J Gynecol Pathol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"505-11","DOI":"10.1007\/s00438-014-0938-x","article-title":"Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.","volume":"290","author":"S Halder","year":"2015","journal-title":"Mol Genet Genomics."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"57-65","DOI":"10.1016\/j.matbio.2011.09.001","article-title":"Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma.","volume":"31","author":"J Norian","year":"2012","journal-title":"Matrix Biol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"7-12","DOI":"10.1517\/14728222.2014.975793","article-title":"Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy.","volume":"19","author":"S Di Tommaso","year":"2015","journal-title":"Expert Opin Ther Targets."},{"key":"ref-21","first-page":"334","article-title":"Biomechanical evaluation of human uterine fibroids after exposure to purified clostridial collagenase","volume":"A743","author":"F Jayes","journal-title":"Biol Reprod."},{"key":"ref-22","first-page":"1556-67","article-title":"Rodent model of reproductive tract leiomyomata. Clinical and pathological features.","volume":"146","author":"J Everitt","year":"1995","journal-title":"Am J Pathol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"e41-e49","DOI":"10.1016\/j.ddstr.2012.06.001","article-title":"Treatment for Uterine Fibroids: Searching for Effective Drug Therapies.","volume":"9","author":"D Taylor","year":"2012","journal-title":"Drug Discov Today Ther Strateg."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1-12","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments.","volume":"31","author":"S Singh","year":"2015","journal-title":"Curr Med Res Opin."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"649-55","DOI":"10.1016\/j.fertnstert.2014.07.008","article-title":"Alternative therapies in management of leiomyomas.","volume":"102","author":"A Patel","year":"2014","journal-title":"Fertil Steril."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"521-33","DOI":"10.1016\/j.ogc.2012.09.005","article-title":"The impact and management of fibroids for fertility: an evidence-based approach.","volume":"39","author":"X Guo","year":"2012","journal-title":"Obstet Gynecol Clin North Am."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"289.e1-9","DOI":"10.1016\/j.ajog.2009.10.885","article-title":"Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.","volume":"202","author":"D Zhang","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"477-86","DOI":"10.2147\/IJWH.S41021","article-title":"Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study.","volume":"5","author":"E Roshdy","year":"2013","journal-title":"Int J Womens Health."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"2177-84","DOI":"10.1016\/j.fertnstert.2008.03.045","article-title":"Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression.","volume":"91","author":"M Malik","year":"2009","journal-title":"Fertil Steril."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"512-7","DOI":"10.3109\/09513590.2010.507287","article-title":"Inhibitory effect of curcumin on uterine leiomyoma cell proliferation.","volume":"27","author":"K Tsuiji","year":"2011","journal-title":"Gynecol Endocrinol."},{"key":"ref-31","doi-asserted-by":"crossref","first-page":"909-14","DOI":"10.1111\/j.1471-0528.1996.tb09911.x","article-title":"Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study.","volume":"103","author":"P Lumbiganon","year":"1996","journal-title":"Br J Obstet Gynaecol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"798-800","DOI":"10.1080\/01443610400009543","article-title":"Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study.","volume":"24","author":"S Venkatachalam","year":"2004","journal-title":"J Obstet Gynaecol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"126-30","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.","volume":"112","author":"G Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"139-48","DOI":"10.1007\/s00404-013-2797-9","article-title":"Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case\u2013control studies.","volume":"288","author":"J Qin","year":"2013","journal-title":"Arch Gynecol Obstet."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"93-100","DOI":"10.2147\/IJWH.S38800","article-title":"Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study.","volume":"5","author":"M Sabry","year":"2013","journal-title":"Int J Womens Health."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"1108-19","DOI":"10.1177\/1933719114537721","article-title":"Paricalcitol, a vitamin D receptor activator, inhibits tumor formation in a murine model of uterine fibroids.","volume":"21","author":"S Halder","year":"2014","journal-title":"Reprod Sci."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"353-8","DOI":"10.2217\/whe.14.24","article-title":"Can vitamin D reduce the risk of uterine fibroids?","volume":"10","author":"A Al-Hendy","year":"2014","journal-title":"Womens Health (Lond Engl)."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"E572-82","DOI":"10.1210\/jc.2014-4011","article-title":"1,25-dihydroxyvitamin d3 regulates expression of sex steroid receptors in human uterine fibroid cells.","volume":"100","author":"A Al-Hendy","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1095\/biolreprod.113.107714","article-title":"1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.","volume":"89","author":"S Halder","year":"2013","journal-title":"Biol Reprod."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1095\/biolreprod.111.098145","article-title":"1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.","volume":"86","author":"S Halder","year":"2012","journal-title":"Biol Reprod."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"E754-62","DOI":"10.1210\/jc.2010-2131","article-title":"1,25-Dihydroxyvitamin D3 reduces TGF-\u03b23-induced fibrosis-related gene expression in human uterine leiomyoma cells.","volume":"96","author":"S Halder","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"447-53","DOI":"10.1097\/EDE.0b013e31828acca0","article-title":"Vitamin D and the risk of uterine fibroids.","volume":"24","author":"D Baird","year":"2013","journal-title":"Epidemiology."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"585-91","DOI":"10.1097\/PGP.0b013e31827630d4","article-title":"Myometrial hyperplasia mimics the clinical presentation of uterine fibroids: a report of 3 cases.","volume":"32","author":"P Newcomb","year":"2013","journal-title":"Int J Gynecol Pathol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"2306-14","DOI":"10.1007\/s00330-013-2819-9","article-title":"How to differentiate benign from malignant myometrial tumours using MR imaging.","volume":"23","author":"I Thomassin-Naggara","year":"2013","journal-title":"Eur Radiol."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/2193-1801-3-294","article-title":"The measurement of stiffness of uterine smooth muscle tumor by elastography.","volume":"3","author":"S Furukawa","year":"2014","journal-title":"Springerplus."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"410-4","DOI":"10.1016\/j.jmig.2014.10.022","article-title":"Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.","volume":"22","author":"M Lieng","year":"2015","journal-title":"J Minim Invasive Gynecol."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"415-25","DOI":"10.1097\/OGX.0000000000000088","article-title":"Uterine morcellation at the time of hysterectomy: techniques, risks, and recommendations.","volume":"69","author":"J Stine","year":"2014","journal-title":"Obstet Gynecol Surv."},{"key":"ref-48","article-title":"Power morcellation and occult malignancy in gynecologic surgery"},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"420-8","DOI":"10.1016\/j.ajog.2009.10.863","article-title":"Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.","volume":"202","author":"M Rodriguez","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"409-20","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery.","volume":"366","author":"J Donnez","year":"2012","journal-title":"N Engl J Med."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"767-72.e1-2","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study.","volume":"95","author":"L Nieman","year":"2011","journal-title":"Fertil Steril."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"630-9","DOI":"10.1016\/j.fertnstert.2014.07.1238","article-title":"Fibroid growth and medical options for treatment.","volume":"102","author":"N Chabbert-Buffet","year":"2014","journal-title":"Fertil Steril."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"3582-9","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial.","volume":"92","author":"N Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"1404-9","DOI":"10.1016\/j.fertnstert.2014.07.1253","article-title":"First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids.","volume":"102","author":"M Luyckx","year":"2014","journal-title":"Fertil Steril."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"1452-9","DOI":"10.1177\/1933719114553449","article-title":"Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids.","volume":"21","author":"L Brunengraber","year":"2014","journal-title":"Reprod Sci."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"2398-406","DOI":"10.1093\/humrep\/det275","article-title":"Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas.","volume":"28","author":"S Nair","year":"2013","journal-title":"Hum Reprod."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"239-50","DOI":"10.1016\/j.fertnstert.2008.09.086","article-title":"Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.","volume":"93","author":"M Hassan","year":"2010","journal-title":"Fertil Steril."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"385-400","DOI":"10.1093\/humupd\/dml015","article-title":"Gene therapy and uterine leiomyoma: a review.","volume":"12","author":"A Al-Hendy","year":"2006","journal-title":"Hum Reprod Update."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/4-183\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/4-183\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/4-183\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T09:51:20Z","timestamp":1553248280000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/4-183\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":58,"URL":"https:\/\/doi.org\/10.12688\/f1000research.6189.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.6634.r9356","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9486","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9355","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9353","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9354","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9355","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9354","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9353","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9486","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.6634.r9356","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/4-183\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.6634.r9353, Donna Day Baird, Laboratory of Women\u2019s Health, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA, 06 Jul 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-183\/v1#referee-response-9353","order":0,"name":"referee-response-9353","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.6634.r9354, Ayman Al-Hendy, Department of Obstetrics and Gynecology, Georgia Regents University, Augusta, GA, 30912, USA, 06 Jul 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-183\/v1#referee-response-9354","order":1,"name":"referee-response-9354","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.6634.r9355, Alicia Armstrong, Contraceptive Discovery and Development Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA, 06 Jul 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-183\/v1#referee-response-9355","order":2,"name":"referee-response-9355","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.6634.r9356, Andrea Tinelli, Department of Gynecology and Obstetrics, Vito Fazzi Hospital, Lecce, Italy, 06 Jul 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-183\/v1#referee-response-9356","order":3,"name":"referee-response-9356","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.6634.r9486, Pasquapina Ciarmela, Polytechnic University of Marche, Ancona, Italy, 14 Jul 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-183\/v1#referee-response-9486","order":4,"name":"referee-response-9486","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":5,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}